CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Grant or award Exec. Vice Chairman/CEO/Pres. acquired 13,470 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Results of operations · Shareholder vote results · Other events
- 4 Other acquisition Director acquired 5,002 shares (other)
- 4 Other acquisition Director acquired 5,002 shares (other)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- S-1/A Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 2,033 shares (other)
Page 27 of 82 · 1,637 filings